FindTrial
Sign In

Enhancing testicular sperm motility by modified pentoxifylline compound

Effect of structurally modified pentoxifylline on human testicular sperm

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/028789
Enrollment
10
Registered
2020-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C621- Malignant neoplasm of descended testis

Interventions

Control Intervention1: NIL: NIL

Sponsors

partially supported by ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: testicular tissue showing presence of spermatozoa

Exclusion criteria

Exclusion criteria: testicular tissue showing presence of spermatozoa in the culture in vitro will be included for the study

Design outcomes

Primary

MeasureTime frame
Enhancing sperm motility in vitro in testicular spermTimepoint: 8 weeks—

Secondary

MeasureTime frame
male infertility treamentTimepoint: 8 weeks—

Countries

India

Contacts

Public ContactSandhya Kumari MV

Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal

sandhya.patil@manipal.edu08660835019

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026